Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of folic acid (vitamin B9), vitamin B6 (pyridoxine), and methylcobalamin (vitamin B12) is a fixed-dose nutritional supplement and therapeutic combination used to treat and prevent vitamin B deficiencies, support cardiovascular health by lowering homocysteine levels, and manage neurological conditions such as peripheral neuropathy. Folic acid is essential for DNA synthesis and red blood cell production. Vitamin B6 is involved in amino acid metabolism and neurotransmitter synthesis. Methylcobalamin, an active form of vitamin B12, is crucial for nerve myelination, DNA synthesis, and red blood cell maturation. Together, these B vitamins act synergistically to support cellular metabolism, nervous system function, and cardiovascular health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on folic acid + vitamin B6 + methylcobalamin.